First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil

Journal of Clinical Microbiology

Volumn 43, Issue 1, 2005, Pages 179-185

  Palazzo, I C V ^a   Araujo, M L C ^b   Darini, A L C ^a  

^a T   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

OXACILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BRAZIL; COAGULASE NEGATIVE STAPHYLOCOCCUS; GENOTYPE; ISOLATION AND PURIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERTANT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; BRAZIL; CARRIER STATE; CELL WALL; COAGULASE; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 11844256408     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.1.179-185.2005     Document Type: Article

References (32)

1. Bignardi, G. E., N. Woodford, A. Chapman, A. P. Johnson, and D. C. Speller. 1996. Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. J. Antimicrob. Chemother. 37:53-63.
2. Bobin-Dubreux, S., M. E. Reverdy, C. Nervi, M. Rougier, A. Bolmström, F. Vandenesch, and J. Etienne. 2001. Clinical isolate of vancomycin-hetero-intermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob. Agents Chemother. 45:349-352.
3. Boyle-Vavra, S., S. K. Berke, J. C. Lee, and R. S. Daum. 2000. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob. Agents Chemother. 44:272-277.
4. Center, K. J., A. C. Reboli, R. Hubler, G. L. Rodgers, and S. S. Long. 2003. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J. Clin. Microbiol. 41:4660-4665.
5. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb. Mortal. Wkly. Rep. 26:565-567.
6. Centers for Disease Control and Prevention. 2004. Brief report: vancomycin-resistant Staphylococcus aureus - New York, 2004. Morb. Mortal. Wkly. Rep. 53:322-323.
7. Cui, L., H. Murakami, K. Kuwara-Arai, H. Hanaki, and K. Hiramatsu. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44:2276-2285.
8. Cui, L., X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M. Mamizuka, C. G. Gemmell, M. N. Kim, M. C. Ploy, N. ElSolh, V. Ferraz, and K. Hiramatsu. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:5-14.
9. Dukta-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
10. File, T. M., Jr. 1999. Overview of resistance in the 1990s. Chest 115(Suppl. 3):S3-S8.
11. Goering, R. V. 1993. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulse-field gel electrophoresis. Infect. Control Hosp. Epidemiol. 14:595-600.
12. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet i:147-155.
13. Hussain, F. M., S. Boyle-Vavra, P. B. Shete, and R. S. Daum. 2002. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. J. Infect. Dis. 186:661-667.
14. Jordens, J. Z. 1998. Genomic DNA digestion and ribotyping, p. 21. In N. Woodford and A. P. Johnson (ed.), Methods in molecular medicine, molecular bacteriology: protocols and clinical applications, vol. 15. Humana Press Inc., Totowa, NJ.
15. Kohner, P., J. Uhl, C. Kolbert, D. Persing, and F. Cockerill III. 1999. Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methiallin) resistance in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus spp. J. Clin. Microbiol. 37:2952-2961.
16. Livermore, D. M. 2000. Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents 16(Suppl.):S3-S10.
17. NCCLS. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. NCCLS, Wayne, Pa.
18. NCCLS. 2002. Performance standards for antimicrobial susceptibility testing: informational supplement M100-S12, vol. 22, no. 1. NCCLS, Wayne, Pa.
19. Oliveira, G. A., A. M. Dell'Aquila, R. L. Masiero, C. E. Levy, M. S. Gomes, L. Cui, K. Hiramatsu, and E. M. Mamizuka. 2001. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect. Control Hosp. Epidemiol. 22:443-448.
20. Pina, P., F. Vandenesch, J. P. Bedos, J. Etienne, and P. Y. Allouch. 2000. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital. Clin. Infect. Dis. 31:1306-1308.
21. Reipert, A., K. Ehlert, T. Kast, and G. Bierbaum. 2003. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob. Agents Chemother. 47:568-576.
22. Schaaff, F., A. Reipert, and G. Bierbaum. 2002. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:3540-3548.
23. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566.
24. Sieradzki, K., T. Leski, J. Dick, L. Borio, and A. Tomasz. 2003. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J. Clin. Microbiol. 41:1687-1693.
25. Smith, A. J., M. S. Jackson, and J. Bagg. 2001. The ecology of Staphylococcus species in the oral cavity. J. Med. Microbiol. 50:940-946.
26. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
27. Tenover, F. C., L. M. Weigel, P. C. Appelbaum, L. C. McDougal, J. Chaitram, S. McAllister, N. Clark, G. Killgore, C. M. O'Hara, L. Jevitt, J. B. Patel, and B. Bozdogan. 2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280.
28. Trakulsomboom, S., S. Danchaivijitr, C. D. Rongrungruang, W. Susaemgrat,., T. Ito, and K. Hiramatsu. 2001. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J. Clin. Microbiol. 39:591-595.
29. Van Der Zwet, W. C., Y. J. Debets-Ossenkopp, E. Reinders, M. Kapi, P. H. M. Savelkoul, R. M. Van Elburg, K. Hiramatsu, and C. M. J. E. Vandenbroucke-Grauls. 2002. Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit. J. Clin. Microbiol. 40:2520-2525.
30. Walker, J., R. Borrow, V. Edward-Jones, B. A. Oppehenheim, and J. A. Fox. 1998. Epidemiological characterization of methicillin-resistant Staphylococcus aureus isolated in the north west of England by protein A (spa) and coagulase (coa) gene polymorphism. Epidemiol. Infect. 121:507-514.
31. Watanakunakorn, C. 1984. Mode of action and in vitro activity of vancomycin. J. Antimicrob. Chemother. 14(Suppl. D):7-18.
32. Woodford, N., D. Morrison, A. P. Johnson, V. Briant, R. C. George, and B. Cookson. 1993. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J. Clin. Microbiol. 31:653-658.